Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus
Authors:
- 1 January 2014
- journal article
- case report
- Published by Elsevier in Antiviral Research
- Vol. 101, 57-61
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Artemisinin-Derived Dimer Diphenyl Phosphate Is an Irreversible Inhibitor of Human Cytomegalovirus ReplicationAntimicrobial Agents and Chemotherapy, 2012
- Antiviral treatment of cytomegalovirus infection: an updateExpert Opinion on Pharmacotherapy, 2012
- Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantationAntiviral Research, 2011
- Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cellsAntiviral Research, 2011
- Drug-resistant cytomegalovirus in transplant recipients: a French cohort studyJournal of Antimicrobial Chemotherapy, 2010
- Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010
- How we treat cytomegalovirus in hematopoietic cell transplant recipientsBlood, 2009
- Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavirReviews in Medical Virology, 2008
- Growth and Drug Resistance Phenotypes Resulting from Cytomegalovirus DNA Polymerase Region III Mutations Observed in Clinical SpecimensAntimicrobial Agents and Chemotherapy, 2007
- Multidrug Resistance Conferred by Novel DNA Polymerase Mutations in Human Cytomegalovirus IsolatesAntimicrobial Agents and Chemotherapy, 2007